Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients

NCT04707742 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Betadine© bucal 100 mg/ml
DRUG: Oximen® 3%
DRUG: Clorhexidine Dental PHB©
DRUG: Vitis Xtra Forte©
DRUG: Distilled Water

Sponsor

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]